En kombination af to i øjeblikket godkendte lægemidler til at forbedre behandlingen af skizofreni
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Fase
Fase
- Fase 2
- Fase 1
Kontakter og lokationer
Studiesteder
-
-
California
-
Cerritos, California, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
Chula Vista, California, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician.
-
Garden Grove, California, Forenede Stater
- For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.
-
San Diego, California, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Connecticut
-
New Haven, Connecticut, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
New Haven, Connecticut, Forenede Stater
- For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Illinois
-
Chicago, Illinois, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Minnesota
-
Minneapolis, Minnesota, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
New Hampshire
-
Lebanon, New Hampshire, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
New York
-
New York, New York, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
North Carolina
-
Butner, North Carolina, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
Chapel Hill, North Carolina, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Oklahoma
-
Okalahoma City, Oklahoma, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Texas
-
Austin, Texas, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
Irvin, Texas, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
Irving, Texas, Forenede Stater
- For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.
-
San Antonio, Texas, Forenede Stater
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician."
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inklusionskriterier:
- Skal have en klinisk diagnose skizofreni
- Skal være mindst 18 år og ikke ældre end 55 år
- Skal have været stabil på en dosis af Abilify, Risperdal, Seroquel eller Zyprexa i de sidste 8 uger
- Kvinder i den fødedygtige alder skal bruge en medicinsk accepteret præventionsmiddel
- Skal kunne sluge kapsler
Ekskluderingskriterier:
- Har andre alvorlige helbredsproblemer end skizofreni
- Tager et antidepressivt middel mod depression
- Tager insulin mod diabetes
- Har en historie med alkohol- eller stofafhængighed (undtagen nikotin og koffein) inden for de seneste 6 måneder
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Psykiske lidelser
- Skizofrenispektrum og andre psykotiske lidelser
- Skizofreni
- Lægemidlers fysiologiske virkninger
- Adrenerge midler
- Neurotransmittermidler
- Molekylære mekanismer for farmakologisk virkning
- Depressive midler til centralnervesystemet
- Autonome agenter
- Agenter fra det perifere nervesystem
- Antiemetika
- Gastrointestinale midler
- Antipsykotiske midler
- Beroligende midler
- Psykotropiske stoffer
- Serotoninoptagelseshæmmere
- Neurotransmitter optagelseshæmmere
- Membrantransportmodulatorer
- Serotoninmidler
- Adrenerge optagelseshæmmere
- Olanzapin
- Atomoxetin hydrochlorid
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 8269 (CTEP)
- H6U-MC-HGLM
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .